Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Stiripentol provides new hope for patients with epilepsy that cannot be effectiv···【more】
Release date：2024-08-28Recommended：256
Stiripentol is specifically used in the treatment of Dravet syndrome-related sei···【more】
Release date：2024-08-28Recommended：262
Dravet syndrome is a rare and refractory epileptic encephalopathy, and Stiripent···【more】
Release date：2024-08-28Recommended：241
Stiripentol is an innovative antiepileptic drug used to treat Dravet syndrome, m···【more】
Release date：2024-08-28Recommended：226
Fidaxomicin is a white to off-white film-coated oblong tablet and should be used···【more】
Release date：2024-08-28Recommended：229
Fidaxomicin works by inhibiting the RNA polymerase of bacteria, which has little···【more】
Release date：2024-08-28Recommended：276
Fidaxomicin is a macrolide antibiotic developed by Optimer and approved by the F···【more】
Release date：2024-08-28Recommended：318
Balversa is specifically designed for patients with advanced urothelial carcinom···【more】
Release date：2024-08-28Recommended：237
Balversa is a targeted drug targeting FGFR mutations for the treatment of advanc···【more】
Release date：2024-08-28Recommended：272
Balversais an oral anti-tumor drug for the treatment of urothelial carcinoma wit···【more】
Release date：2024-08-28Recommended：226
Balversa is a new anti-cancer drug targeting FGFR, targeting urothelial carcinom···【more】
Release date：2024-08-28Recommended：258
Balversais an oral anti-cancer drug mainly used for the treatment of advanced or···【more】
Release date：2024-08-28Recommended：336
